uveal neoplasms

Summary

Summary: Tumors or cancer of the UVEA.

Top Publications

  1. ncbi Small ciliary body tumors: ultrasound biomicroscopic assessment and follow-up of 42 patients
    Daniel J Weisbrod
    Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada
    Am J Ophthalmol 141:622-8. 2006
  2. ncbi Frequent mutation of BAP1 in metastasizing uveal melanomas
    J William Harbour
    Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St Louis, MO 63110, USA
    Science 330:1410-3. 2010
  3. ncbi Bevacizumab suppression of establishment of micrometastases in experimental ocular melanoma
    Hua Yang
    Department of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia, USA
    Invest Ophthalmol Vis Sci 51:2835-42. 2010
  4. ncbi Regulation of VEGF-A in uveal melanoma
    Mariam El Filali
    Department of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands
    Invest Ophthalmol Vis Sci 51:2329-37. 2010
  5. ncbi Emerging insights into the molecular pathogenesis of uveal melanoma
    Solange Landreville
    Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St Louis, MO 63110, USA
    Future Oncol 4:629-36. 2008
  6. ncbi Vascular endothelial growth factor is elevated in ocular fluids of eyes harbouring uveal melanoma: identification of a potential therapeutic window
    S R Boyd
    Department of Pathology, Institute of Ophthalmology, University College London, Bath Street, London EC1V 9EL, UK
    Br J Ophthalmol 86:448-52. 2002
  7. ncbi MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met
    Dongsheng Yan
    School of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical College, Wenzhou, Zhejiang, People s Republic of China
    Invest Ophthalmol Vis Sci 50:1559-65. 2009
  8. ncbi Inhibitor of apoptosis proteins gene expression and its correlation with prognostic factors in primary and metastatic uveal melanoma
    Michal Lederman
    Ophthalmology, Hadassah Hebrew University Medical Center, Hebrew University School of Medicine, Jerusalem, Israel
    Curr Eye Res 33:876-84. 2008
  9. ncbi Expression of vascular endothelial growth factor in uveal melanoma and its correlation with metastasis
    T G Sheidow
    Department of Ophthalmology, University of Western Ontario, London, Canada
    Br J Ophthalmol 84:750-6. 2000
  10. ncbi P53 apoptosis mediator PERP: localization, function and caspase activation in uveal melanoma
    Lyndsay Davies
    Unit of Ophthalmology, School of Clinical Sciences, University of Liverpool, Liverpool, United Kingdom
    J Cell Mol Med 13:1995-2007. 2009

Research Grants

  1. OCULAR MELANOMA
    Paul Finger; Fiscal Year: 2003
  2. THE ROLE OF RB IN THE RETINA & OTHER TISSUES
    JAMES HARBOUR; Fiscal Year: 2009
  3. THE ROLE OF RB IN THE RETINA & OTHER TISSUES
    JAMES HARBOUR; Fiscal Year: 2004
  4. Molecular Predictive Testing in Ocular Melanoma
    JAMES HARBOUR; Fiscal Year: 2007
  5. MICROCIRCULATION OF UVEAL MELANOMA
    Robert Folberg; Fiscal Year: 2007
  6. THE ROLE OF RB IN THE RETINA & OTHER TISSUES
    JAMES HARBOUR; Fiscal Year: 2007
  7. MICROCIRCULATION OF UVEAL MELANOMA
    Robert Folberg; Fiscal Year: 2002
  8. Molecular Predictive Testing in Ocular Melanoma
    JAMES W HARBOUR; Fiscal Year: 2010
  9. Molecular Predictive Testing in Ocular Melanoma
    JAMES HARBOUR; Fiscal Year: 2009
  10. AAV-Based Plasmacytoid Dendritic Cell Cancer Vaccine
    Pierre Triozzi; Fiscal Year: 2009

Detail Information

Publications191 found, 100 shown here

  1. ncbi Small ciliary body tumors: ultrasound biomicroscopic assessment and follow-up of 42 patients
    Daniel J Weisbrod
    Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada
    Am J Ophthalmol 141:622-8. 2006
    ..UBM can be used to assess various internal tumor features; however, arriving at a specific diagnosis without histologic correlation is difficult...
  2. ncbi Frequent mutation of BAP1 in metastasizing uveal melanomas
    J William Harbour
    Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St Louis, MO 63110, USA
    Science 330:1410-3. 2010
    ..These findings implicate loss of BAP1 in uveal melanoma metastasis and suggest that the BAP1 pathway may be a valuable therapeutic target...
  3. ncbi Bevacizumab suppression of establishment of micrometastases in experimental ocular melanoma
    Hua Yang
    Department of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia, USA
    Invest Ophthalmol Vis Sci 51:2835-42. 2010
    ..This study was undertaken to determine whether anti-vascular endothelial growth factor (VEGF) therapy inhibits growth of primary uveal melanoma and spread of its hepatic micrometastases...
  4. ncbi Regulation of VEGF-A in uveal melanoma
    Mariam El Filali
    Department of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands
    Invest Ophthalmol Vis Sci 51:2329-37. 2010
    ..This study was undertaken to examine the regulation of the proangiogenic factor vascular endothelial growth factor (VEGF-A)...
  5. ncbi Emerging insights into the molecular pathogenesis of uveal melanoma
    Solange Landreville
    Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St Louis, MO 63110, USA
    Future Oncol 4:629-36. 2008
    ..Taken together, this pathogenetic scheme can be used to construct a molecularly based and prognostically relevant classification of uveal melanomas that can be used clinically for personalized patient management...
  6. ncbi Vascular endothelial growth factor is elevated in ocular fluids of eyes harbouring uveal melanoma: identification of a potential therapeutic window
    S R Boyd
    Department of Pathology, Institute of Ophthalmology, University College London, Bath Street, London EC1V 9EL, UK
    Br J Ophthalmol 86:448-52. 2002
    ....
  7. ncbi MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met
    Dongsheng Yan
    School of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical College, Wenzhou, Zhejiang, People s Republic of China
    Invest Ophthalmol Vis Sci 50:1559-65. 2009
    ..MicroRNA-34a (miR-34a), a potential key effector of the p53 tumor-suppressor gene, was studied as a potential tumor suppressor in uveal melanoma...
  8. ncbi Inhibitor of apoptosis proteins gene expression and its correlation with prognostic factors in primary and metastatic uveal melanoma
    Michal Lederman
    Ophthalmology, Hadassah Hebrew University Medical Center, Hebrew University School of Medicine, Jerusalem, Israel
    Curr Eye Res 33:876-84. 2008
    ..We aimed to evaluate the expression of IAPs in uveal melanoma (UM) and its correlation with prognostic factors associated with death from metastatic UM...
  9. ncbi Expression of vascular endothelial growth factor in uveal melanoma and its correlation with metastasis
    T G Sheidow
    Department of Ophthalmology, University of Western Ontario, London, Canada
    Br J Ophthalmol 84:750-6. 2000
    ..To evaluate the expression of vascular endothelial growth factor (VEGF) in uveal melanomas and correlate its presence with tumour characteristics and systemic metastasis...
  10. ncbi P53 apoptosis mediator PERP: localization, function and caspase activation in uveal melanoma
    Lyndsay Davies
    Unit of Ophthalmology, School of Clinical Sciences, University of Liverpool, Liverpool, United Kingdom
    J Cell Mol Med 13:1995-2007. 2009
    ..The findings underline the apoptotic pathway mediated by PERP as a critical mechanism employed by UM tumours to modulate susceptibility to apoptosis...
  11. ncbi Oncogenic GNAQ mutations are not correlated with disease-free survival in uveal melanoma
    J Bauer
    Department of Dermatology, University of Tübingen Medical Center, Liebermeisterstr 25, Tubingen 72076, Germany
    Br J Cancer 101:813-5. 2009
    ..Recently, oncogenic G protein alpha subunit q (GNAQ) mutations have been described in about 50% of uveal melanomas and in the blue nevi of the skin...
  12. ncbi Vascular endothelial growth factor a in eyes with uveal melanoma
    Guy S O Missotten
    Departments of Ophthalmology, Pathology, and Medical Statistics, Leiden University Medical Center, Leiden
    Arch Ophthalmol 124:1428-34. 2006
    ..Aqueous VEGF-A concentration correlates with largest basal tumor diameter and with the tumor height. In eyes with uveal melanoma, tumor and retinal tissues are sources of VEGF-A...
  13. ncbi Functional analysis of the p53 pathway in response to ionizing radiation in uveal melanoma
    Young Sun
    Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO, USA
    Invest Ophthalmol Vis Sci 46:1561-4. 2005
    ..Further elucidation of p53 pathway abnormalities in uveal melanoma may allow therapeutic interventions to increase the radiosensitivity of the tumors...
  14. ncbi Expression of angiogenic factors Cyr61 and tissue factor in uveal melanoma
    Teresa M Walker
    Department of Ophthalmology and Visual Sciences, University of Wisconsin Medical School, Room K6/466 Clinical Sciences Center, Madison, WI 53792, USA
    Arch Ophthalmol 120:1719-25. 2002
    ..CLINICAL RELEVANCE: New immunotherapies have been devised for the treatment of cancer based on the expression of TF. Similar approaches may be effective in treating uveal melanoma...
  15. ncbi Expression of vascular endothelial growth factor a, matrix metalloproteinase 9 and extravascular matrix patterns in iris and ciliary body melanomas
    Afsun Sahin
    Department of Ophthalmology, Ocular Oncology Service, Hacettepe University School of Medicine, Ankara, Turkey
    Ophthalmic Res 39:40-4. 2007
    ....
  16. ncbi The heterogeneous distribution of monosomy 3 in uveal melanomas: implications for prognostication based on fine-needle aspiration biopsies
    Willem Maat
    Department of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands
    Arch Pathol Lab Med 131:91-6. 2007
    ..Fine-needle aspiration biopsy is being used to detect monosomy 3 in these tumors, based on the assumption that this chromosomal abnormality is distributed homogeneously throughout the tumor...
  17. ncbi Molecular genetics of uveal melanoma
    Amy E Loercher
    Department of Ophthalmology and Visual Sciences, Washington University, School of Medicine, St. Louis, MO 63110, USA
    Curr Eye Res 27:69-74. 2003
    ..Herein, we review the findings to date, discuss the insights they provide, and suggest future directions for molecular research in uveal melanoma...
  18. ncbi Single-cell tumor dormancy model of uveal melanoma
    Patrick T Logan
    The Henry C Witelson Ophthalmic Pathology Laboratory and Registry, McGill University Health Center, Montreal, QC, Canada
    Clin Exp Metastasis 25:509-16. 2008
    ..It has been reported that difficulties in imaging single cells and the propensity for tumor cells to replicate rapidly in animal models account for the deficit of single-cell tumor dormancy models...
  19. ncbi Evidence of macrophage and lymphocyte, but not dendritic cell, infiltration in posterior uveal melanomas, whilst cultured uveal melanomas demonstrate pluripotency by expressing CD68 and CD163
    Julia Woodward
    Academic Unit of Ophthalmology and Orthoptics, University of Sheffield, Royal Hallamshire Hospital, Sheffield, UK
    Int J Exp Pathol 85:35-43. 2004
    ..Expression of the leucocyte antigen CD45 was observed in three tumours but was not present in any cultured cells, whilst the expression of the dendritic cell marker CD1a was absent from all samples...
  20. ncbi Expression of vascular endothelial growth factor-A, matrix metalloproteinase-9, and extravascular matrix patterns and their correlations with clinicopathologic parameters in posterior uveal melanomas
    Afsun Sahin
    Ocular Oncology Service, Department of Ophthalmology, Hacettepe University School of Medicine, Ankara, Turkey
    Jpn J Ophthalmol 51:325-31. 2007
    ....
  21. ncbi Expression of the receptor tyrosine kinase Axl promotes ocular melanoma cell survival
    Paul R Van Ginkel
    Department of Ophthalmology and Visual Sciences, University of Wisconsin Medical School, Madison, Wisconsin 53792, USA
    Cancer Res 64:128-34. 2004
    ..These data show that the Axl pathway mediates increased survival of uveal melanoma cells, potentially advantageous during cancer dormancy, and that Axl may function in part through regulation of Cyr61...
  22. ncbi Angiogenic profile of uveal melanoma
    Irene Christa Notting
    Department of Ophthalmology, Leiden University Medical Centre, Leiden, The Netherlands
    Curr Eye Res 31:775-85. 2006
    ..Our data suggest that the expression of (lymph) angiogenic factors may play a causal role in the angiogenesis and progression of uveal melanoma and distant metastasis...
  23. ncbi Decreased endothelin receptor B expression in large primary uveal melanomas is associated with early clinical metastasis and short survival
    S L Smith
    Gene Function Group, Roy Castle International Centre for Lung Cancer Research, 200 London Road, Liverpool L3 9TA, UK
    Br J Cancer 87:1308-13. 2002
    ..Our findings suggest a role for endothelin receptor type B in the metastasis of uveal melanoma and, potentially, in the metastasis of other neural crest tumours...
  24. ncbi DNA ploidy and S-phase fraction as prognostic factors in patients with uveal melanomas
    M Karlsson
    Department of Oncology, University Hospital, , Sweden
    Br J Cancer 71:177-81. 1995
    ..We further conclude that patients with small DNA diploid uveal melanomas of spindle cell type have a rather favourable prognosis...
  25. ncbi Genomic investigations of posterior uveal melanoma
    Peter G Hovland
    Schepens Retina Associates, Boston, MA 02215, USA
    Semin Ophthalmol 20:231-8. 2005
    ..As an improved understanding of the cellular mechanisms used by uveal melanoma is gained, new opportunities to adapt or design therapeutic approaches may emerge...
  26. ncbi An accurate, clinically feasible multi-gene expression assay for predicting metastasis in uveal melanoma
    Michael D Onken
    Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St Louis, MO 63110, USA
    J Mol Diagn 12:461-8. 2010
    ..This prognostic assay provides an important addition to the armamentarium for managing patients with uveal melanoma, and it provides a proof of principle for the development of similar assays for other cancers...
  27. ncbi Expression of p53-induced apoptosis effector PERP in primary uveal melanomas: downregulation is associated with aggressive type
    Luminita Paraoan
    Unit of Ophthalmology, School of Clinical Sciences, University of Liverpool, UCD Building, Daulby Street, Liverpool L69 3GA, UK
    Exp Eye Res 83:911-9. 2006
    ....
  28. ncbi Variation of monosomy 3 status within uveal melanoma
    Lynn Schoenfield
    Department of Anatomic Pathology, and the Cole Eye Institute, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH 44195, USA
    Arch Pathol Lab Med 133:1219-22. 2009
    ..Monosomy 3, one such variable, can be determined using fluorescence in situ hybridization, either on enucleated samples, fine-needle aspiration biopsy, or tumor sample obtained by vitrector...
  29. ncbi p53 Immunoreactivity, Ki-67 expression, and microcirculation patterns in melanoma of the iris, ciliary body, and choroid
    Itay Chowers
    Department of Ophthalmology, The Hebrew University-Hadassah Medical School, Jerusalem, Israel
    Curr Eye Res 24:105-8. 2002
    ..CONCLUSIONS: The findings suggest that alterations in p53 expression are associated with the expression of the cellular proliferation marker, Ki-67, but are not associated with the presence of microcirculation patterns...
  30. ncbi Vasculogenic mimicry and tumor angiogenesis
    R Folberg
    Department of Pathology, University of Illinois at Chicago, Chicago, Illinois, USA
    Am J Pathol 156:361-81. 2000
    ..The unique patterning characteristic of vasculogenic mimicry provides an opportunity to design noninvasive imaging techniques to detect highly aggressive neoplasms and their metastases...
  31. ncbi Integrative genomic analysis of aneuploidy in uveal melanoma
    Justis P Ehlers
    Wills Eye Hospital, Philadelphia, Pennsylvania, USA
    Clin Cancer Res 14:115-22. 2008
    ..Uveal melanoma is an attractive solid tumor for studying aneuploidy because it is a relatively homogeneous cancer that is highly metastatic and has low nonspecific chromosomal instability...
  32. ncbi Uveal melanoma: epidemiologic aspects
    Arun D Singh
    Department of Ophthalmic Oncology, Cole Eye Institute, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Ophthalmol Clin North Am 18:75-84, viii. 2005
    ....
  33. ncbi Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death
    Michael D Onken
    Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, Missouri, USA
    Cancer Res 64:7205-9. 2004
    ..These studies offer new insights into melanoma pathogenesis, and they provide a practical foundation for effective clinical predictive testing...
  34. ncbi Intraocular melanocytoma in association with bone formation
    Paul Hiscott
    Arch Ophthalmol 121:1791-4. 2003
  35. ncbi Variates of survival in metastatic uveal melanoma
    Petra Rietschel
    Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
    J Clin Oncol 23:8076-80. 2005
    ..Data on variates of survival and site of first metastasis may guide strategies for screening patients, although our data failed to show a survival advantage in discovering asymptomatic metastatic disease...
  36. ncbi Risk of uveal melanoma
    Andrea Schmidt-Pokrzywniak
    Ophthalmology 114:1418; author reply 1418. 2007
  37. ncbi Transcriptomic versus chromosomal prognostic markers and clinical outcome in uveal melanoma
    Lori A Worley
    Department of Ophthalmology and Visual Sciences, Washington University, St Louis, Missouri 63110, USA
    Clin Cancer Res 13:1466-71. 2007
    ..To compare a gene expression-based classifier versus the standard genetic prognostic marker, monosomy 3, for predicting metastasis in uveal melanoma...
  38. ncbi Concurrent loss of chromosome arm 1p and chromosome 3 predicts a decreased disease-free survival in uveal melanoma patients
    Emine Kilic
    Department of Ophthalmology, Erasmus MC, Rotterdam, The Netherlands
    Invest Ophthalmol Vis Sci 46:2253-7. 2005
    ..001). CONCLUSIONS: In uveal melanoma, concurrent loss of the short arm of chromosome 1 and all of chromosome 3 is an independent predictor of decreased DFS...
  39. ncbi Occupational risks for uveal melanoma results from a case-control study in nine European countries
    Jean-Michel Lutz
    Registre Genevois des Tumeurs, Geneva, Switzerland
    Cancer Causes Control 16:437-47. 2005
    ..CONCLUSION: Our study does overall not support an association between occupational sunlight exposure and risk of uveal melanoma. The finding of an excess risk of eye melanoma in cooks in several European countries is intriguing...
  40. ncbi Intermittent and chronic ultraviolet light exposure and uveal melanoma: a meta-analysis
    Chirag P Shah
    Harvard School of Public Health, Boston, Massachusetts, USA
    Ophthalmology 112:1599-607. 2005
    ..To examine the association between ultraviolet light exposure and uveal melanoma...
  41. ncbi Cell proliferation profile of five human uveal melanoma cell lines of different metastatic potential
    Jean Claude Marshall
    The Henry C Witelson Ocular Pathology Laboratory and Registry, McGill University, Montreal, Canada
    Pathobiology 71:241-5. 2004
    ..The aim of this study was to establish a proliferation profile of uveal melanoma cell lines, using different methods, and to compare it with their previously determined metastatic potential (MP)...
  42. ncbi International uveal melanoma incidence trends in view of a decreasing proportion of morphological verification
    Andreas Stang
    Institute of Medical Epidemiology, Biometry and Informatics, University Clinics of Halle, Saale, Germany
    Int J Cancer 114:114-23. 2005
    ..Uveal melanoma incidence rates remained quite stable during the period 1983-97. The interpretation of uveal melanoma incidence trends is complicated by missing data on topography within the eye, morphology and basis of diagnosis...
  43. ncbi Prognostic value of serum VEGF in melanoma patients: a pilot study
    Paolo Antonio Ascierto
    Division of Clinical Immunology, National Cancer Institute, Via M. Semmola, 80131 Naples, Italy
    Anticancer Res 24:4255-8. 2004
    ..048 at log-rank test). CONCLUSION: Our results suggest that serum VEGF could be of prognostic value in melanoma...
  44. ncbi Pathological and prognostic features of uveal melanomas
    Ian W McLean
    Department of Ophthalmic Pathology, Armed Forces Institute of Pathology, Washington, DC, USA
    Can J Ophthalmol 39:343-50. 2004
    ..Other valuable prognostic factors are tumour-infiltrating lymphocytes and macrophages, and the presence of vascular loops...
  45. ncbi Local excision of ciliary body tumors: a long-term prospective cohort study in China
    Wen bin Wei
    Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China
    Chin Med J (Engl) 121:2152-6. 2008
    ..Therefore, we reported the outcome of locally excised ciliary body tumors after long-term follow-up...
  46. ncbi Noncontiguous tumor recurrence of posterior uveal melanoma after transscleral local resection
    Jonathan W Kim
    Ocular Oncology Service, Royal Liverpool University Hospital, Prescot Street, Liverpool L7 8XP, England
    Arch Ophthalmol 120:1659-64. 2002
    ..To describe the clinical and histopathologic features of noncontiguous tumor recurrence after transscleral local resection of posterior uveal melanoma...
  47. ncbi Identification of circulating malignant cells and its correlation with prognostic factors and treatment in uveal melanoma. A prospective longitudinal study
    S A Callejo
    Henry C Witelson Ophthalmic Pathology Laboratory and Registry, McGill University Health Center, Montreal, Quebec, Canada
    Eye (Lond) 21:752-9. 2007
    ..The purpose of the study was to detect circulating malignant cells (CMCs) in UMP and to correlate them with prognostic factors and therapy...
  48. ncbi Cell proliferation activity in posterior uveal melanoma after Ru-106 brachytherapy: an EORTC ocular oncology group study
    J Pe'er
    Department of Ophthalmology, Hadassah University Hospital, Jerusalem, Israel
    Br J Ophthalmol 85:1208-12. 2001
    ..To evaluate the cell proliferation activity in posterior uveal melanomas after Ru-106 brachytherapy...
  49. ncbi A metastasis modifier locus on human chromosome 8p in uveal melanoma identified by integrative genomic analysis
    Michael D Onken
    Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St Louis, Missouri, USA
    Clin Cancer Res 14:3737-45. 2008
    ....
  50. ncbi Occupational risk factors, ultraviolet radiation, and ocular melanoma: a case-control study in France
    P Guenel
    INSERM Unité 88, Hopital National de Saint Maurice, Saint Maurice, France
    Cancer Causes Control 12:451-9. 2001
    ..Ultraviolet radiation has been suspected as a possible cause of ocular melanoma. Because this association is controversial, we examine the role of occupational exposure to ultraviolet radiation on the occurrence of this rare cancer...
  51. ncbi Micro-RNAs associated with metastasis in uveal melanoma identified by multiplexed microarray profiling
    Lori A Worley
    Department of Ophthalmology and Visual Sciences and Siteman Comprehensive Cancer Center, Washington University School of Medicine, St Louis, Missouri, USA
    Melanoma Res 18:184-90. 2008
    ..miRNA expression may represent a highly accurate biomarker for metastatic risk in uveal melanoma. In addition, these results may provide new insights into the role of miRNAs in tumor progression and the metastatic phenotype...
  52. ncbi Survival rates with uveal melanoma in the United States: 1973-1997
    Arun D Singh
    Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
    Ophthalmology 110:962-5. 2003
    ..CONCLUSIONS: Advances made in the local methods of treatment of primary uveal melanoma have not led to an improvement in survival. Systemic approaches to management of uveal melanoma are warranted...
  53. ncbi Tumor classification based on gene expression profiling shows that uveal melanomas with and without monosomy 3 represent two distinct entities
    Frank Tschentscher
    , , 45122 Essen, Germany
    Cancer Res 63:2578-84. 2003
    ..Our findings suggest that there are two distinct entities of uveal melanoma that were previously unrecognized because they are not obviously distinguishable by clinicopathological features...
  54. ncbi Mobile phones and malignant melanoma of the eye
    C Johansen
    Danish Cancer Society, Institute of Cancer Epidemiology, Strandboulevarden 49, , Denmark
    Br J Cancer 86:348-9. 2002
    ..Our study provides no support for an association between mobile phones and ocular melanoma...
  55. ncbi Cooking and uveal melanoma risk: results from two German case-control studies
    Andreas Stang
    Institute for Medical Informatics, Biometry and Epidemiology, Medical Faculty, University of Essen, Germany
    Cancer Causes Control 14:377-80. 2003
    ..Two recent studies indicated that cooks may have an increased risk of uveal melanoma. Here we report findings of two German case-control studies regarding cooking and uveal melanoma risk...
  56. ncbi Ultrasound biomicroscopic findings in a cavitary melanocytoma of the ciliary body
    Carmen Capeans
    Ocular Oncology Service, Department of Ophthalmology, Complejo Hospitalario Universitario de Santiago de Compostela, Spain
    Can J Ophthalmol 38:501-3. 2003
  57. ncbi Comparative analysis of integrins in vitro and in vivo in uveal and cutaneous melanomas
    J F Marshall
    Richard Dimbleby Department of Cancer Research, Rayne Institute, St Thomas Hospital, London
    Br J Cancer 77:522-9. 1998
    ....
  58. ncbi The possible role of radiofrequency radiation in the development of uveal melanoma
    A Stang
    Institute for Medical Informatics, Biometry and Epidemiology, Medical Faculty, University of Essen, Germany
    Epidemiology 12:7-12. 2001
    ..This is the first study describing an association between radiofrequency radiation exposure and uveal melanoma. Several methodologic limitations prevent our results from providing clear evidence on the hypothesized association...
  59. ncbi Regional deletion and amplification on chromosome 6 in a uveal melanoma case without abnormalities on chromosomes 1p, 3 and 8
    Walter van Gils
    Departments of Clinical Genetics, Erasmus MC, Rotterdam, The Netherlands
    Melanoma Res 18:10-5. 2008
    ..1-6q22 and the presence of one or more oncogenes on chromosomal region 6pter-6p21.2, which are likely to be important in UM and other tumors...
  60. ncbi Uveal tumour resection
    D H Char
    The Tumori Eye Foundation, CPMC Davies, Stanford University, CA 94114, USA
    Br J Ophthalmol 85:1213-9. 2001
    ..To review the ocular retention rates, visual results, and metastases in uveal tumours managed with eye wall resection techniques...
  61. ncbi Uveal melanoma survival in Sweden from 1960 to 1998
    Louise Bergman
    St Erik s Eye Hospital, Radiumhemmet, Karolinska Hospital, Stockholm, Sweden
    Invest Ophthalmol Vis Sci 44:3282-7. 2003
    ..To investigate the crude and relative survival rates in patients with uveal melanoma in Sweden during the period from 1960 to 1998...
  62. ncbi Tumor-infiltrating macrophages (CD68(+) cells) and prognosis in malignant uveal melanoma
    T Mäkitie
    Ocular Oncology Service and Ophthalmic Pathology Laboratory, Department of Ophthalmology, Helsinki University Central Hospital, Finland
    Invest Ophthalmol Vis Sci 42:1414-21. 2001
    ..To investigate the hypothesis that tumor-infiltrating macrophages contribute to prognosis of uveal melanoma and to study their association with tumor characteristics, especially microvessels...
  63. ncbi Positive interaction between light iris color and ultraviolet radiation in relation to the risk of uveal melanoma: a case-control study
    Andrea Schmidt-Pokrzywniak
    Clinical Epidemiology Unit, Institute of Medical Epidemiology, Biometry and Informatics, Medical Faculty, University of Halle Wittenberg, Halle, Germany
    Ophthalmology 116:340-8. 2009
    ..To examine the association among phenotypic characteristics, chronic and intermittent ultraviolet (UV) radiation, and the risk of uveal melanoma...
  64. ncbi Electro-oculographic abnormality in eyes with uveal melanoma
    L Spadea
    Eye Clinic, University of L Aquila, L Aquila, Italy
    Eur J Ophthalmol 12:419-23. 2002
    ..To seek out correlations between preoperative electro-oculogram (EOG) recordings with different types of uveal melanomas, after surgery...
  65. ncbi Apoptosis inhibitor, survivin, in posterior uveal melanoma: comparison among primary tumors, tumors resistant to brachytherapy, tumors with liver metastases, and liver metastases
    Guy J Ben Simon
    Goldschleger Eye Institute, Sheba Medical Center, Israel
    Curr Eye Res 31:251-7. 2006
    ....
  66. ncbi Pigmented episcleral deposits after brachytherapy of uveal melanoma
    Päivi Toivonen
    Ocular Oncology Service, Department of Ophthalmology, Helsinki University Central Hospital, Helsinki, Finland
    Ophthalmology 113:865-73. 2006
    ..To describe the characteristics and evolution of pigmented episcleral deposits after brachytherapy for uveal melanoma to determine their origin and association with melanoma-related mortality...
  67. ncbi HLA Class I and II genotype in uveal melanoma: relation to occurrence and prognosis
    Willem Maat
    Department of Ophthalmology, Leiden University Medical Center, Keiden, The Netherlands
    Invest Ophthalmol Vis Sci 47:3-6. 2006
    ..This does not exclude an important role for HLA antigens in immune surveillance against uveal melanoma and their metastases...
  68. ncbi Complications in patients with uveal melanoma after stereotactic radiosurgery and brachytherapy
    A Furdova
    Department of Ophthalmology, Faculty of Medicine, Comenius University, Bratislava, Slovakia
    Bratisl Lek Listy 106:401-6. 2005
    ..g. secondary glaucoma), after brachytherapy (Ru106 plaques), it was 5%. Conservative methods and combined techniques are effective methods for the therapy of uveal melanomas (Fig. 5, Tab. 1, Ref. 6)...
  69. ncbi Proton beam radiotherapy for uveal melanoma: results of Curie Institut-Orsay proton therapy center (ICPO)
    Remi Dendale
    Department of Radiation Oncology, Curie Institut, Paris, France
    Int J Radiat Oncol Biol Phys 65:780-7. 2006
    ..This study reports the results of proton beam radiotherapy based on a retrospective series of patients treated for uveal melanoma at the Orsay Center...
  70. ncbi Estimates of ocular and visual retention following treatment of extra-large uveal melanomas by proton beam radiotherapy
    R Max Conway
    Department of Ophthalmology, University of California, San Francisco 94143-0730, USA
    Arch Ophthalmol 124:838-43. 2006
    ..CONCLUSION: Proton beam radiotherapy is an ocular-conserving option that may be considered for the treatment of extra-large uveal melanoma in carefully selected patients...
  71. ncbi Cytogenetics of uveal melanoma: a 7-year clinical experience
    Bertil Damato
    Ocular Oncology Service, Royal Liverpool University Hospital, Liverpool, United Kingdom
    Ophthalmology 114:1925-31. 2007
    ..Since 1999, we have offered cytogenetic analysis to patients treated by local resection or enucleation. This study correlated our cytogenetic results with clinical and histologic predictors and disease-specific mortality...
  72. ncbi High-frequency ultrasound characteristics of 24 iris and iridociliary melanomas: before and after plaque brachytherapy
    Paul T Finger
    The New York Eye Cancer Center, Department of Ophthalmology, New York University School of Medicine, 115 E 61st St, New York, NY 10065, USA
    Arch Ophthalmol 125:1051-8. 2007
    ..To evaluate size, characteristics, and regression of iris and iridociliary melanomas on high-frequency ultrasound images before and after plaque brachytherapy...
  73. ncbi Ciliary body melanoma with limited nodular extrascleral extension and diffuse iris-angle infiltration treated by whole anterior segment plaque radiotherapy
    Michael E Gray
    University of Cincinnati College of Medicine, Cincinnati, OH, USA
    Int Ophthalmol 27:273-6. 2007
    ..We report a patient with ciliary body melanoma associated with nodular extrascleral extension and diffuse infiltration of the iris and angle treated conservatively because the fellow eye was blind...
  74. ncbi Ciliary body melanoma simulating multiple iris cysts
    Jørgen Krohn
    Department of Ophthalmology, Haukeland University Hospital, University of Bergen, N 5021 Bergen, Norway
    Arch Ophthalmol 125:428-9. 2007
  75. ncbi Iridociliary melanoma associated with ocular melanocytosis in a 6-year-old boy
    Amina Malik Rahman
    Department of Ophthalmology, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267 0527, USA
    J AAPOS 12:312-3. 2008
    ..Ocular melanocytosis can be associated with uveal melanoma even in young children...
  76. ncbi [High-dose 106Ruthenium plaque brachytherapy for posterior uveal melanoma. A clinico-pathologic study]
    L M Heindl
    Augenklinik mit Poliklinik, Universitat Erlangen Nurnberg, Schwabachanlage 6, 91054, Erlangen, Germany
    Ophthalmologe 104:149-57. 2007
    ..The purpose of this study was to report the multifactorial results of high-dose (106)Ruthenium plaque brachytherapy for (cilio-)choroidal melanoma and to confirm them by histological examinations...
  77. ncbi Routes of extraocular extension of uveal melanoma: risk factors and influence on survival probability
    Sarah E Coupland
    Department of Pathology, School of Clinical Sciences, University of Liverpool, Liverpool, United Kingdom
    Ophthalmology 115:1778-85. 2008
    ..To correlate extraocular spread with other survival predictors and with metastatic death and determine whether there was any relationship between the size of the extraocular tumor and survival...
  78. ncbi Progressive enlargement of cavity within melanoma masquerading as iris cyst
    Jonathan S Criss
    Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA 19107, USA
    Cornea 25:863-5. 2006
    ..CONCLUSION: Cavitation can occur in ciliary body melanoma and can lead to misinterpretation as a cyst. Cavitary melanoma should be considered in the differential diagnosis of cystic lesions of the anterior segment...
  79. ncbi Treatment considerations for primary uveal melanoma with choroidal metastasis to the fellow eye
    Dan H Bourla
    Jules Stein Eye Institute, Ocular Oncology Center, David Geffen UCLA School of Medicine, Los Angeles, CA 90095, USA
    Semin Ophthalmol 22:175-7. 2007
    ..Again, observation was recommended. In conclusion, systemic spread of primary choroidal melanoma may include a choroidal metastasis to the contralateral eye. Observation of the second affected eye may be prescribed...
  80. ncbi Uveal malignant melanoma with extrascleral extension, treated with plaque radiotherapy
    W J Muen
    Eye 21:307-8. 2007
  81. ncbi Reduced melanoma-related mortality in uveal melanoma by preenucleation radiotherapy
    Emine Kilic
    Department of Ophthalmology, Erasmus MC, Rotterdam, The Netherlands
    Arch Ophthalmol 123:1363-7. 2005
    ..5% and 25.2%, respectively. In both groups, women had a better prognostic outcome than men. CONCLUSION: This study suggests that PER improves long-term survival in patients with uveal melanoma...
  82. ncbi Ring melanoma of the anterior chamber angle: a report of fourteen cases
    H Demirci
    Oncology Service, Wills Eye Hospital, Thomas Jefferson University, 900 Walnut St, Philadelphia, PA 19107, USA
    Am J Ophthalmol 132:336-42. 2001
    ..Despite the relatively small tumor volume, life prognosis is guarded with distant metastasis in 25% at mean 6 years follow-up...
  83. ncbi Very long-term prognosis of patients with malignant uveal melanoma
    Emma Kujala
    Ocular Oncology Service, Department of Ophthalmology, Helsinki University Central Hospital, Helsinki, Finland
    Invest Ophthalmol Vis Sci 44:4651-9. 2003
    ..To investigate the very long-term prognosis of patients with uveal melanoma and the clinical characteristics influencing it...
  84. ncbi Iodine brachytherapy as an alternative to enucleation for large uveal melanomas
    Ilkka Puusaari
    Ocular Oncology Service, Department of Ophthalmology, Helsinki University Central Hospital, Helsinki, Finland
    Ophthalmology 110:2223-34. 2003
    ..To evaluate the safety and efficacy of iodine 125 plaque brachytherapy (IBT) for large uveal melanomas...
  85. ncbi [Circumstances of choroid and ciliary body melanoma detection]
    E Frau
    Service d'Ophtalmologie, , 78, , , France
    J Fr Ophtalmol 26:905-10. 2003
    ..001), which were more frequently the largest lesions. CONCLUSION: These results emphasize the importance of early detection of uveal melanoma. We recommended frequent fundus examination after pupil dilatation...
  86. ncbi [Phase 2 clinical study of 123I-N-(2-diethylaminoethyl)-2-iodobenzamide in the diagnostic of primary and metastatic ocular melanoma]
    I Sillaire-Houtmann
    Service d'Ophtalmologie, CHU, , Clermont-Ferrand
    J Fr Ophtalmol 27:34-9. 2004
    ..CONCLUSION: BZA2 scintigraphy showed good tolerance in patients and it appears promising for differential diagnosis, staging, and restaging of melanoma...
  87. ncbi [Ciliary body melanomas. Survival and prognostic aspects after brachytherapy or proton therapy]
    J Gambrelle
    Service d'Ophtalmologie, , Lyon
    J Fr Ophtalmol 27:40-7. 2004
    ..Largest tumor diameter over 13mm, presence of exudative retinal detachment, and macroscopic iris root involvement at the time of diagnosis are important risk factors for melanoma-related death, as shown by the multivariate analysis...
  88. ncbi Observation of suspected choroidal and ciliary body melanomas for evidence of growth prior to enucleation. 1980
    J Donald M Gass
    Retina 23:523-8. 2003
  89. ncbi Comparison of prognosis after enucleation vs cobalt 60 irradiation of melanomas. 1985
    J Donald M Gass
    Retina 23:916-23. 2003
  90. ncbi Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays)
    F Rouberol
    University Eye Clinic, Hopital de la Croix Rousse, 103 Grande Rue de la Croix Rousse, 69004 Lyon, France
    Am J Ophthalmol 137:893-900. 2004
    ..To analyze survival, radiation-related complications, local recurrence, enucleation, and visual acuity after ruthenium-106 irradiation of malignant uveal melanoma...
  91. ncbi Survival after proton-beam irradiation of uveal melanomas
    L Kodjikian
    Department of Ophtalmology, Croix Rousse Hospital, and Laboratory of Biomaterials and Matrix Remodelling, Claude Bernard University, Lyon, France
    Am J Ophthalmol 137:1002-10. 2004
    ..To evaluate the independent prognostic factors for survival, metastasis, local recurrence, and enucleation in patients who had undergone proton-beam therapy for posterior uveal melanomas...
  92. ncbi Macrophages and microcirculation in regressed and partially regressed irradiated choroidal and ciliary body melanomas
    Päivi Toivonen
    Ocular Oncology Service, Department of Ophthalmology, Helsinki University Central Hospital, Helsinki, Finland
    Curr Eye Res 27:237-45. 2003
    ..To investigate how tumour-infiltrating macrophages and microcirculation attributes of uveal melanomas regressed after brachytherapy and whether primarily enucleated melanomas differ...
  93. ncbi Plaque radiotherapy for choroidal and ciliochoroidal melanomas with limited nodular extrascleral extension
    James J Augsburger
    Ocular Oncology Service, Department of Ophthalmology, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267 0527, USA
    Can J Ophthalmol 39:380-7. 2004
    ..Currently available clinical information regarding management of posterior uveal melanomas complicated by nodular extrascleral extension is inadequate to determine the role, if any, for plaque radiotherapy in such patients...
  94. ncbi Have choroidal and ciliary body melanomas changed during the period 1955-2000?
    Peter Isager
    Department of Experimental Clinical Oncology, Arhus University Hospital, Arhus, Denmark
    Acta Ophthalmol Scand 82:509-16. 2004
    ..To establish whether the presentation of choroidal and ciliary body melanomas and patient survival have changed during the period 1955-2000...
  95. ncbi Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas
    Peter Isager
    Department of Experimental Clinical Oncology, Arhus University Hospital, Arhus, Denmark
    Acta Ophthalmol Scand 82:517-25. 2004
    ..To evaluate prognostic factors for the survival of patients treated by enucleation for choroidal and ciliary body melanomas...
  96. ncbi Prognostic value of the disodium phosphate 32P uptake test in uveal melanoma: a long-term study
    Esther N M Overkleeft
    Department of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands
    Arch Ophthalmol 121:1398-403. 2003
    ..CONCLUSIONS: The 32P isotope uptake test has no prognostic value for uveal melanoma. Moreover, the results of this study indicate that it is unlikely that cell activity as determined by 32P uptake involves mitotic activity of the tumor...
  97. ncbi Metastasis-free survival following treatment for uveal melanoma with either stereotactic radiosurgery or enucleation
    V M L Cohen
    Department of Ophthalmology, Addenbrookes Hospital, Cambridge, UK
    Acta Ophthalmol Scand 81:383-8. 2003
    ..To determine whether metastasis-free survival following stereotactic radiosurgery is comparable with that following enucleation in a cohort of patients with choroidal and ciliary body melanoma...
  98. ncbi Uveal melanoma and poor treatment compliance: an atypical outcome with literature review
    William L Park
    The Wilmer Ophthalmological Institute, The Johns Hopkins University, School of Medicine, Baltimore, Maryland, USA
    Optom Vis Sci 80:344-55. 2003
    ..Until recently, data were limited regarding growth characteristics and at what stage metastases are likely to occur...
  99. ncbi Insulin-like growth factor-1 receptor in uveal melanoma: a predictor for metastatic disease and a potential therapeutic target
    Charlotta All-Ericsson
    St. Erik's Eye Hospital, Stockholm, Sweden
    Invest Ophthalmol Vis Sci 43:1-8. 2002
    ..These data also point to the possibility of therapeutically interfering with IGF-1R, which appears to be expressed preferentially in uveal melanomas that appear to follow an aggressive clinical course...
  100. ncbi [Conservative treatment of choroidal melanoma using iodine-125 brachytherapy, technique and preliminary analysis of 78 patients]
    P Quetin
    Departement de Radiotherapie, Centre Paul Strauss, 3, rue de la Porte de l Hôpital, 67085 Strasbourg, France
    Cancer Radiother 5:737-42. 2001
    ..The technique used to achieve these results was simplified through the physical characteristics of the radioelement and the optimized-dosimetry program employed...
  101. ncbi Altered expression of Rb and p53 in uveal melanomas following plaque radiotherapy
    Milam A Brantley
    Center for Ocular Oncology, Department of Ophthalmology and Visual Sciences and Division of Molecular Oncology, Washington University School of Medicine, St. Louis, Missouri 63110, USA
    Am J Ophthalmol 133:242-8. 2002
    ..Plaque radiotherapy can also cause alterations in the expression of Rb, but the significance of this finding will require further study...

Research Grants104 found, 100 shown here

  1. OCULAR MELANOMA
    Paul Finger; Fiscal Year: 2003
    ..Standardized clinical and data collection procedures will be employed, and standardized forms will be used in all centers. Central training and certification of all study staff will be required. ..
  2. THE ROLE OF RB IN THE RETINA & OTHER TISSUES
    JAMES HARBOUR; Fiscal Year: 2009
    ..Consequently, these aims are highly relevant to the vision statement of the NEI, and they address several major program goals and objectives of the Retinal Diseases Program. ..
  3. THE ROLE OF RB IN THE RETINA & OTHER TISSUES
    JAMES HARBOUR; Fiscal Year: 2004
    ..abstract_text> ..
  4. Molecular Predictive Testing in Ocular Melanoma
    JAMES HARBOUR; Fiscal Year: 2007
    ....
  5. MICROCIRCULATION OF UVEAL MELANOMA
    Robert Folberg; Fiscal Year: 2007
    ..abstract_text> ..
  6. THE ROLE OF RB IN THE RETINA & OTHER TISSUES
    JAMES HARBOUR; Fiscal Year: 2007
    ..Consequently, these aims are highly relevant to the vision statement of the NEI, and they address several major program goals and objectives of the Retinal Diseases Program. ..
  7. MICROCIRCULATION OF UVEAL MELANOMA
    Robert Folberg; Fiscal Year: 2002
    ..The investigators expect to show that ultrasonographic criteria based on power image spectrum parameters can provide a noninvasive substitute for biopsy. ..
  8. Molecular Predictive Testing in Ocular Melanoma
    JAMES W HARBOUR; Fiscal Year: 2010
    ..This research proposal represents an application of this strategy and provides a proof of principle for similar approaches in other cancers. ..
  9. Molecular Predictive Testing in Ocular Melanoma
    JAMES HARBOUR; Fiscal Year: 2009
    ....
  10. AAV-Based Plasmacytoid Dendritic Cell Cancer Vaccine
    Pierre Triozzi; Fiscal Year: 2009
    ....
  11. AAV-Based Plasmacytoid Dendritic Cell Cancer Vaccine
    Pierre Triozzi; Fiscal Year: 2007
    ....
  12. Uveal Melanoma Micrometastasis
    Pierre L Triozzi; Fiscal Year: 2010
    ..Micrometastases, microscopic deposits of tumor that have spread via the bloodstream, are present in many patients with uveal melanoma at diagnosis. This project will test new methods of identifying and inhibiting these deposits. ..
  13. AAV-Based Plasmacytoid Dendritic Cell Cancer Vaccine
    Pierre L Triozzi; Fiscal Year: 2010
    ....
  14. TRH Production and Regulation by Human Melanoma
    Julie Ellerhorst; Fiscal Year: 2006
    ..In Specific Aim #2, cell lines will be used for in vitro studies to determine if one or more of the mechanisms of hypothalamic TRH regulation are relevant to the control of TRH production by melanoma cells. ..
  15. TRANSPLANT AND TUMOR REJECTION PROCESSES WITHIN THE EYE
    Jerry Niederkorn; Fiscal Year: 2002
    ..g., corneal transplantation) or abrogate immune privilege to protect against sight- and life-threatening neoplasms. ..
  16. IMMUNOBIOLOGY OF CORNEAL ALLOGRAFTS
    Jerry Niederkorn; Fiscal Year: 2010
    ..These studies will lead to improved strategies for re-establishing immune privilege of corneal transplants and offsetting the untoward effects of allergic diseases on the fate of corneal transplants. ..
  17. TRANSPLANT AND TUMOR REJECTION PROCESSES WITHIN THE EYE
    Jerry Niederkorn; Fiscal Year: 2007
    ....
  18. Thyroid Stimulating Hormone Promotes the Growth and Progression of Human Melanoma
    Julie Ellerhorst; Fiscal Year: 2007
    ..Medications used to treat hypothyroidism may actually be therapeutic for melanoma. Furthermore, melanoma cases may be prevented by heightened surveillance of individuals with a history of hypothyroidism. ..
  19. TRANSPLANT AND TUMOR REJECTION PROCESSES WITHIN THE EYE
    Jerry Niederkorn; Fiscal Year: 2006
    ..g., corneal transplantation). In some cases, it may be desirable to abrogate immune privilege to promote the immune-rejection of sight- and life-threatening ocular neoplasms. ..
  20. IMMUNOLOGICAL MODULATION OF OCULAR TUMOR METASTASES
    Jerry Niederkorn; Fiscal Year: 2006
    ..The long rang goal of this project is to design, develop, and evaluate novel immunotherapeutic modalities for the prevention and treatment of uveal melanoma metastases. ..
  21. IMMUNOBIOLOGY OF CORNEAL ALLOGRAFTS
    Jerry Niederkorn; Fiscal Year: 2001
    ..Both strategies procure antigen-specific suppression of host immune responses and should prove useful in preventing corneal graft rejection. ..
  22. TRANSPLANT AND TUMOR REJECTION PROCESSES WITHIN THE EYE
    Jerry Niederkorn; Fiscal Year: 1992
    ..Understanding immune privilege may lead to strategies for promoting long term survival of therapeutic organ grafts...
  23. FACTORS INVOLVED IN MALIGNANT BEHAVIOR OF HUMAN TUMORS
    Liliana Ossowski; Fiscal Year: 2007
    ....
  24. TRANSPLANT AND TUMOR REJECTION PROCESSES WITHIN THE EYE
    Jerry Niederkorn; Fiscal Year: 2009
    ....
  25. Experimental Uveal Melanoma and Ocular Immune Privilege
    KYLE MCKENNA; Fiscal Year: 2007
    ..abstract_text> ..
  26. TRANSPLANT AND TUMOR REJECTION PROCESSES WITHIN THE EYE
    Jerry Niederkorn; Fiscal Year: 2003
    ..g., corneal transplantation). In some cases, it may be desirable to abrogate immune privilege to promote the immune-rejection of sight- and life-threatening ocular neoplasms. ..
  27. TRANSPLANT AND TUMOR REJECTION PROCESSES WITHIN THE EYE
    Jerry Niederkorn; Fiscal Year: 1993
    ..The long range goals of this project are to understand immune regulatory processes in the eye and to manipulate such processes to reduce immune-mediated injury and corneal graft rejection...
  28. IMMUNOBIOLOGY OF CORNEAL ALLOGRAFTS
    Jerry Niederkorn; Fiscal Year: 2006
    ..All three of these aims will be addressed in a well-characterized mouse model of penetrating keratoplasty. ..
  29. OCULAR MELANOMA
    Dennis Robertson; Fiscal Year: 2003
    ..Standardized clinical and data collection procedures will be employed; and standardized forms will be used in all centers. Central training and certification of all study staff will be required. ..
  30. PERICYTES IN ANGIOGENESIS IN NEUROFIBROMATOSIS TYPE 1
    Ugur Ozerdem; Fiscal Year: 2003
    ..3) The investigators will examine the effect of the NF1-/- and NF1-/+ genotypes on microvascularization in embryonic development. The ability of NG2 ablation to rescue micro and macrovascular defects will be determined. ..
  31. Targeting Vasculogenesis and Interstitial Hypertension in Neurofibromatosis Type1
    Ugur Ozerdem; Fiscal Year: 2007
    ....
  32. IMMUNOBIOLOGY OF CORNEAL ALLOGRAFTS
    Jerry Niederkorn; Fiscal Year: 2007
    ..These studies will lead to improved strategies for re-establishing immune privilege of corneal transplants and offsetting the untoward effects of allergic diseases on the fate of corneal transplants. ..